Arrowhead Research | ARWR - Créances Commerciales





Créances Commerciales Changement Date
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 17M 54M 2026-06
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 9.85B 252M 2026-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
TG Therapeutics USD 392.05M 86.42M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xencor USD 12M 17.3M 2026-03